Details of the Drug Formulaction

General Information of Drug Formulation (ID: F05861)

• Formulation Name: Didanosine 200 mg capsule
• Company: Teva Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Didanosine	(DMI2QPE)	Human immunodeficiency virus infection	1C62	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Allura red AC dye	(E00338)	33258	Colorant
Carmellose sodium	(E00625)	Not Available	Disintegrant
D&C red no. 33	(E00261)	19116	Colorant
FD&C blue no. 1	(E00263)	19700	Colorant
FD&C blue no. 2	(E00446)	2723854	Colorant
Ferrosoferric oxide	(E00231)	14789	Colorant
Propylene glycol	(E00040)	1030	Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Quinoline yellow WS	(E00309)	24671	Colorant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium hydroxide	(E00234)	14798	Alkalizing agent
Sunset yellow FCF	(E00255)	17730	Colorant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Triacetin	(E00080)	5541	Humectant; Plasticizing agent; Solvent
Triethyl citrate	(E00128)	6506	Plasticizing agent; Solvent